Feb 10, 2022

Artificial Intelligence Can Identify Genetic Disorders in Embryo With Simple Blood Test

Posted by in categories: biotech/medical, genetics, robotics/AI

New Israeli startup aims to get product to market within two years; technology could also be used to identify early markers of cancer.

An Israeli startup is developing a non-invasive early detection method using artificial intelligence (AI) to identify genetic disorders in human embryos.

Via a simple blood test taken from the pregnant mother during the first trimester, IdentifAI Genetics can read the embryo’s entire DNA and provide in-depth analysis to detect genetic disorders.

Comments are closed.